Concentrations of α- and β-defensins in gastric juice of patients with various gastroduodenal diseases

World Journal of Gastroenterology

Volumn 11, Issue 1, 2005, Pages 99-103

  Nishi, Yoshito ^a   Isomoto, Hajime ^a,c   Mukae, Hiroshi ^a   Ishimoto, Hiroshi ^a   Wen, Chun Yang ^a   Wada, Akihiro ^a   Ohnita, Ken ^a   Mizuta, Yohei ^a   Murata, Ikuo ^a   Hirayama, Toshiya ^a   Nakazato, Masamitsu ^b   Kohno, Shigeru ^a  

^a NAGASAKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b UNIVERSITY OF MIYAZAKI   (Japan)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Gastroduodenal diseases; Helicobacter pylori infection; defensins; defensin

Indexed keywords

ALPHA DEFENSIN; BETA DEFENSIN 1; BETA DEFENSIN 2; BIOLOGICAL MARKER; PEPSINOGEN I; PEPSINOGEN II;

ADULT; AGED; ARTICLE; ATROPHY; CHRONIC GASTRITIS; CONCENTRATION RESPONSE; CORRELATION ANALYSIS; DUODENUM ULCER; FEMALE; GASTROINTESTINAL DISEASE; GASTROINTESTINAL ENDOSCOPY; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; MAJOR CLINICAL STUDY; MALE; MUCOSA INFLAMMATION; PROTEIN BLOOD LEVEL; RADIOIMMUNOASSAY; STOMACH JUICE; STOMACH MUCOSA; STOMACH POLYP; STOMACH ULCER;

EID: 19944429168     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v11.i1.99     Document Type: Article

References (31)

1. van Wetering S, Sterk PJ, Rabe KF, Hiemstra PS. Defensins: Key players or bystanders in infection, injury, and repair in the lung. J Allergy Clin Immunol 1999; 104: 1131-1138
2. Chertov O, Yang D, Howard OMZ, Oppenheim JJ. Leukocyte granule proteins mobilize innate host defenses and adaptive immune responses. Immunol Rev 2000; 177: 68-78
3. Bals R. Epithelial antimicrobial peptides in host defense against infection. Respir Res 2000; 1: 141-150
4. Wada A. Studies on biological activity of antimicrobial peptides, defensins, and the inducible mechanism in mammalian cells. Nippon Saikingaku Zasshi 2003; 58: 595-602
5. Oppenheim JJ, Biragyn A, Kwak LW, Yang D. Roles of antimicrobial peptides such as defensins in innate and adaptive immunity. Ann Rheum Dis 2003; 62(Suppl 2): ii17-21
6. Blaser MJ. Helicobacter pylori and the pathogenesis of gastroduodenal inflammation. J Infect Dis 1990; 161: 626-633
7. Ernst PB, Gold BD. The disease spectrum of Helicobacter pylori: the immunopathogenesis of gastroduodenal ulcer and gastric cancer. Ann Rev Microbiol 2000; 54: 615-640
8. Li H, Stoicov C, Cai X, Wang TC, Houghton J. Helicobacter and gastric cancer disease mechanisms: host response and disease susceptibility. Curr Gastroenterol Rep 2003; 5: 459-467
9. Naumann M, Crabtree JE. Helicobacter pylori induced epithelial cell signalling in gastric carcinogenesis. Trends Microbiol 2004; 12: 29-36
10. Moss SF, Sood S. Helicobacter pylori. Curr Opin Infect Dis 2003; 16: 445-451
11. Borch K, Skarsgard J, Franzen L, Mardh S, Rehfeld JF. Benign gastric polyps: Morphological and functional origin. Dig Dis Sci 2003; 48: 1292-1297
12. O'Neil DA, Cole SP, Martin-Porter E, Housley MP, Liu L, Ganz T, Kagnoff MF. Regulation of human β-defensins by gastric epithelial cells in response to infection with Helicobacter pylori or stimulation with interleukin-1. Infect Immun 2000; 68: 5412-5415
13. Bajaj-Elliott M, Smith GV, Domizio P, Maher L, Ali RS, Quinn AG, Farthing MJG. Modulation of host antimicrobial peptide (β-defensins 1 and 2) expression during gastritis. Gut 2002; 51 356-361
14. Uehara N, Yagihashi A, Kondoh K, Tsuji N, Fujita T, Hamada H, Watanabe N. Human β-defensin-2 induction in Helicobacter pylori-infected gastric mucosal tissues: antimicrobial effect of overexpression. J Med Microbiol 2003; 52: 41-45
15. Hamanaka Y, Nakashima M, Wada A, Ito M, Kurazono H, Hoji H, Nakahara Y, Kohno S, Hirayama T, Sekine I. Expression of human β-defensin 2 (hBD-2) in Helicobacter pylori induced gastritis: Antibacterial effect of hBD-2 against Helicobacter pylori. Gut 2001; 49: 481-487
16. Wehkamp J, Schmidt K, Herrlinger KR, Baxmann S, Behling S, Wohlschlager C, Feller AC, Stange EF, Fellermann K. Defensin pattern in chronic gastritis: HBD-2 is differentially expressed with respect to Helicobacter pylori status. J Clin Pathol 2003; 56: 352-357
17. Hiratsuka T, Nakazato M, Date Y, Ashitani JI, Minematsu T, Chino N, Matsukura S. Identification of human beta-defensin-2 in respiratory tract and plasma and its increase in bacterial pneumonia. Biochem Biophys Res Commun 1998; 249: 943-947
18. Nakazato M, Shiomi K, Date Y, Matsukura S, Kangawa K, Minamino N, Matsuo H. Isolation and sequence determinants of 6- and 8-kDa precursors of human neutrophil peptides from bone marrow, plasma and peripheral blood neutrophils. Biochem Biophys Res Commun 1995; 211: 1053-1062
19. Broutet N, Plebani M, Sakarovitch C, Sipponen P, Megraud F. Pepsinogen A, pepsinogen C, and gastrin as markers of atrophic chronic gastritis in European dydpeptics. Br J Cancer 2003; 88 1239-1247
20. Korstanje A, den Hartog G, Biemond I, Lamersc B. The serological gastric biopsy: A non-endoscopical diagnostic approach in management of the dyspeptic patient significance for primary care based on a survey of the literature. Scand J Gastroenterol 2002; 37 22-26
21. Thomson ABR, Appleman S, Keelan M, Wallace JL. Role of gastric mucosal and gastric juice cytokine concentrations in development of biophosphonate damage to gastric mucosa. Dig Dis Sci 2003; 48 308-314
22. Ashitani J, Mukae H, Nakazato M, Taniguchi H, Ogawa K, Kohno S, Matsukura S. Elevated pleural fluid levels of defensins in patients with empyema. Chest 1998; 113: 788-794
23. Hiratsuka T, Mukae H, Iiboshi H, Ashitani J, Nabeshima K, Minematsu T, Chino N, Ihi T, Kohno S, Nakazato M. Increased concentrations of human β-defensins in plasma and bronchoalveolar lavage fluid of patients with diffuse panbronchiolitis. Thorax 2003; 58 425-430
24. George JT, Boughan PK, Karageorgiou H, Bajaj-Elliott M. Host anti-microbial response to Helicobacter pylori infection. Mol Immunol 2003; 40: 451-456
25. Ohara H, Isomoto H, Wen CY, Ejima C, Murata M, Miyazaki M, Takeshima F, Mizuta Y, Murata I, Koji T, Nagura H, Kohno S. Expression of mucosal addressin cell adhesion molecule 1 on vascular endothelium of gastric mucosa in patients with nodular gastritis. World J Gastroenterol 2003; 9: 2701-2705
26. Sipponen P, Harkonen M, Alanko A, Suovaniemi O. Diagnosis of atrophic gastritis from a serum sample. Clin Lab 2002; 48: 505-515
27. Miki K. Evaluation of the serum pepsinogen level as a method to screen stomach cancer. Nippon Naika Gakkai Zasshi 2000; 89: 1942-1947
28. Stemmermann GN, Fenoglio-Preiser C. Gastric carcinoma distal to the cardia: A review of the epidemiological pathology of the precusors to a preventable cancer. Pathology 2002; 34: 494-503
29. Fukuda Y, Isomoto H, Ohnita K, Omagari K, Mizuta Y, Murase K, Murata I, Moriuchi H, Kohno S. Impact of CagA status on serum gastrin and pepsinogen I and II concentrations in Japanese children with Helicobacter pylori infection. J Int Med Res 2003; 31: 247-252
30. Isomoto H, Mizuta Y, Inoue K, Matsuo T, Hayakawa T, Miyazaki M, Onita K, Takeshima F, Murase K, Shimokawa I, Kohno S. A close relationship between Helicobacter pylori infection and gastric xanthoma. Scand J Gastroenterol 1999; 34: 346-352
31. Zhao C, Wang I, Lehrer RI. Widespread expression of β-defensin hBD-1 in human secretory glands and epithelial cells. FEBS Lett 1996; 396: 319-322